Brera Holdings PLC Currently in Diligence Phase to Buy Serie B Italian Professional Football Club
June 04, 2024 08:55 ET
|
Brera Holdings PLC
Brera (Nasdaq:BREA), in response to media reports, reiterates that it’s in due diligence phase for the potential acquisition of a football/soccer team
BioRestorative Therapies, Inc. to attend the Jefferies 2024 Healthcare Conference
June 04, 2024 08:50 ET
|
BioRestorative Therapies, Inc
MELVILLE, NY., June 04, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRestorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies,...
Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
June 04, 2024 08:42 ET
|
Predictive Oncology Inc.
Predictive Oncology’s organ-specific in vitro models are designed to better mimic the physiological environment of human tissue The 3D cell culture market is projected to grow by more than 14%...
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety
June 04, 2024 08:41 ET
|
Silo Pharma, Inc.
Clinical roadmap unveiled for novel and proprietary intranasal PTSD treatment SARASOTA, FL, June 04, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a...
Enact to Participate at the 2024 TD Financial Services and Fintech Summit
June 04, 2024 08:40 ET
|
Enact Holdings, Inc.
RALEIGH, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced that the company’s President and Chief Executive Officer, Rohit Gupta, will participate in...
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
June 04, 2024 08:30 ET
|
Surrozen, Inc.
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
XORTX to Present at BIO International Convention 2024
June 04, 2024 08:30 ET
|
XORTX Therapeutics Inc.
CALGARY, June 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on...
Grom’s Top Draw Animation to Showcase Premium 2D Animation Production Servies for Global Industry Leaders at Annecy 2024
June 04, 2024 08:30 ET
|
Grom Social Enterprises
Grom’s Top Draw Animation to Showcase Premium 2D Animation Production Servies for Global Industry Leaders at Annecy 2024
Artelo Biosciences Presents Important New Data on ART26.12 at the 57th Annual Scientific Meeting of the British Pain Society
June 04, 2024 08:30 ET
|
Artelo Biosciences
SOLANA BEACH, Calif., June 04, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop...
Chair of UC Berkeley Nuclear Engineering Department Joins NANO Nuclear Energy as Lead Developer of ‘ZEUS’ Portable Microreactor
June 04, 2024 08:30 ET
|
NANO Nuclear Energy Inc.
Prof. Massimiliano Fratoni to spearhead development of the next generation, portable, on-demand capable, advanced nuclear microreactor New York, N.Y., June 04, 2024 (GLOBE NEWSWIRE) -- NANO...